Previous close | 26.10 |
Open | 25.98 |
Bid | 26.20 x 200 |
Ask | 26.28 x 200 |
Day's range | 25.92 - 26.34 |
52-week range | 25.76 - 48.60 |
Volume | |
Avg. volume | 495,647 |
Market cap | 1.221B |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | 29.49 |
EPS (TTM) | 0.89 |
Earnings date | 01 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 46.40 |
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term...
In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts. To skip our analysis of the recent market activity, you can go directly to see the Aggressive Stock Portfolio: 5 Stocks Picked by Analysts. By definition, aggressive stocks are ones that offer higher returns than conservative and relatively […]
TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 23rd Annual Needham Virtual Healthcare Conference at 8:00 AM ET on Monday, April 8, 2024. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences,